ABRYSVO is indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older, and pregnant individuals at 32 through 36 weeks gestational age.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/1dcN5BP
No comments:
Post a Comment